Griseofulvin, microsize - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for griseofulvin, microsize and what is the scope of freedom to operate?

Griseofulvin, microsize is the generic ingredient in three branded drugs marketed by Valeant Luxembourg, Actavis Mid Atlantic, Chartwell Rx, Cipla, Cosette, Sandoz, and Sigmapharm Labs Llc, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

Seven suppliers are listed for this compound.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Valeant Luxembourg	GRIFULVIN V	griseofulvin, microsize	SUSPENSION;ORAL	062483-001	Jan 26, 1984		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Sigmapharm Labs Llc	GRISEOFULVIN	griseofulvin, microsize	TABLET;ORAL	202482-001	Oct 22, 2012	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Rx	FULVICIN-U/F	griseofulvin, microsize	TABLET;ORAL	060569-001	Approved Prior to Jan 1, 1982	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Valeant Luxembourg	GRIFULVIN V	griseofulvin, microsize	TABLET;ORAL	062279-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	3
Applicants:	7
NDAs:	9
Finished Product Suppliers / Packagers:	7
Raw Ingredient (Bulk) Api Vendors:	96
Patent Applications:	7,529
DailyMed Link:	griseofulvin, microsize at DailyMed

Drug Class	Tubulin Inhibiting Agent
Physiological Effect	Decreased Mitosis Microtubule Inhibition